Kura Oncology
KURA
215 hedge funds and large institutions have $888M invested in Kura Oncology in 2025 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 91 increasing their positions, 54 reducing their positions, and 27 closing their positions.
69% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 54
63% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 27
29% more call options, than puts
Call options by funds: $4.19M | Put options by funds: $3.24M
20% more capital invested
Capital invested by funds: $743M → $888M (+$146M)
8% more funds holding
Funds holding: 200 → 215 (+15)
1.47% more ownership
Funds ownership: 96.65% → 98.13% (+1.5%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$16.7M |
| 2 |
Renaissance Technologies
New York
|
+$10.1M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$8.6M |
| 4 |
NFT
Nan Fung Trinity
Central, Hong Kong,
Hong Kong
|
+$7.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Algert Global
San Francisco,
California
|
-$8.96M |
| 2 |
Goldman Sachs
New York
|
-$8.16M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$7.72M |
| 4 |
Millennium Management
New York
|
-$5.34M |
| 5 |
BlackRock
New York
|
-$5.29M |
KURA Hedge Fund Activity: Q4 2025 in Review
215 of the 8,265 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2025, worth a combined $888M — up 20% from $743M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new KURA positions and 27 closed out — a net gain of 17 holders — while 91 added to existing stakes and 54 trimmed.
The largest buyer was State Street, adding an estimated $16.7M. The largest seller was Algert Global, exiting entirely with an estimated $8.96M sold.
- 215 institutional investors held Kura Oncology (KURA) as of Q4 2025, up from 200 in Q3 2025.
- Funds reported $888M of Kura Oncology stock for Q4 2025, up 20% quarter-over-quarter.
- 44 funds opened new Kura Oncology positions in Q4 2025 and 27 closed out, a net change of +17 holders.
- The largest Kura Oncology buyer in Q4 2025 was State Street, an estimated $16.7M added.
- The largest Kura Oncology seller in Q4 2025 was Algert Global, an estimated $8.96M sold.
Based on aggregated 13F filings for Q4 2025.